The German Federal Patent Court has asked the CJEU how its “implicitly, but necessarily and specifically” test for assessing Article 3(a) of
A new question has been referred to the European Court of Justice by the German Federal Patent Court on the availability of supplementary protection
The High Court recently dismissed a request to hear an infringement action in respect of the German designation of a European patent. In reaching
The EU Supplementary Protection Certificate (SPC) Regulation (4692006) has been the subject of extensive analysis and numerous referrals to the
Good news could be on the horizon for stem cell patenting in Europe, following the advocate general's opinion in the most recent stem cell case to be
The contentious issue of patent extensions for pharmaceutical products has again come under the spotlight in a recent decision: Actavis v Boehringer
"hES cell patents in Europe - the inescapable Brustle trap?" discussed the controversy regarding human embryonic stem cell (hES cell) patents in
The UK High Court recently asked the European Court of Justice to clarify what is meant by the “first authorisation” for the purposes of calculating the duration of an supplementary protection certificate (SPC).
In a judgment that echoed with resentment over the opacity of several recent Court of Justice of the European Union decisions in the area of supplementary protection certificate law, the Hon Mr Justice Arnold of the UK High Court has decided to refer two questions back to the ECJ, saying in effect “try again"!
The First Chamber of the Court of Justice of the European Union has given its judgment dismissing the appeal brought jointly by Helena Rubenstein and L’Oréal against the 2010 judgment of the EU General Court in favour of Allergan, Inc, owner of the BOTOX trademark.